By Turna Ray

Highlighting its desire to ink more Rx/Dx partnerships, Qiagen is expanding its pharma business development team, which it recently established to manage new drug-diagnostic co-development programs with pharmaceutical companies.

"What we're doing is we're prioritizing the pharma segment," Stephen Little, Qiagen's vice president for personalized healthcare, told Pharmacogenomics Reporter this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

Researchers report that what scents someone picks up can reflect their complement of immune genes.